SLNO
Soleno Therapeutics Inc
NASDAQ: SLNO · HEALTHCARE · BIOTECHNOLOGY
$52.78
+0.04% today
Updated 2026-04-29
Market cap
$2.73B
P/E ratio
135.33
P/S ratio
14.34x
EPS (TTM)
$0.39
Dividend yield
—
52W range
$29 – $90
Volume
3.8M
WallStSmart proprietary scores
41
out of 100
Grade: D
Sell
Investment rating
4.3
Growth
C6.8
Quality
B6.0
Profitability
B4.0
Valuation
C5/9
Piotroski F-Score
Moderate
1.6
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →201 stocks currently score above 75
Price targets
Analyst target
$53.00
+0.42%
12-Month target
$2.65
-94.98%
Intrinsic (DCF)
—
Margin of safety
—
2 Strong Buy11 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $48.65M — positive
Risks
- Altman Z 1.64 — distress zone
- P/E 135.33x — expensive valuation
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $190.41M | $190.41M |
| Net income | $-24.07M | $-38.99M | $-175.85M | $20.89M | $43.36M |
| EPS | — | — | — | — | $0.39 |
| Free cash flow | $-20.79M | $-24.94M | $-69.31M | $46.73M | $48.65M |
| Profit margin | — | — | — | 10.97% | 11.00% |
Peer comparison
Smart narrative
Soleno Therapeutics Inc trades at $52.78. representing a P/E of 135.33x trailing earnings. Our Smart Value Score of 41/100 indicates the stock is fair. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of 1.64, it sits in the distress. TTM revenue stands at $190.41M. with profit margins at 11.00%.
Frequently asked questions
What is Soleno Therapeutics Inc's stock price?
Soleno Therapeutics Inc (SLNO) trades at $52.78.
Is Soleno Therapeutics Inc overvalued?
Smart Value Score 41/100 (Grade D, Sell).
What is the price target of Soleno Therapeutics Inc (SLNO)?
The analyst target price is $53.00, representing +0.4% upside from the current price of $52.78.
What is Soleno Therapeutics Inc's revenue?
TTM revenue is $190.41M.
Piotroski F-Score?
5/9 — moderate financial health.
Altman Z-Score?
1.64 — distress.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio14.34x
ROE6.01%
Beta-2.81
50D MA$42.18
200D MA$54.55
Shares out0.05B
Float0.05B
Short ratio—
Avg volume3.8M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—